A batch of Ramipril 10mg capsules from Crescent Pharma Limited is being recalled due to a possible manufacturing error that could mean some cartons contain 5mg blister strips inside 10mg packaging.

The risk to patients from brief exposure to the lower 5mg dose is very low, and any potential harm would likely develop gradually rather than immediately.

If a carton contains 5mg blister strips, patients should contact their dispensing pharmacy and follow guidance; if the carton is correctly labeled as 10mg, no action is required.

Editors should note the MHRA recall notice, reiterate the regulator’s role in the UK medicines system, and include media contact details.

Regulatory and safety communications emphasize monitoring for adverse effects and removing affected products from supply to protect patients, while acknowledging the low risk from brief exposure to a lower dose.

This is a Class 2 recall affecting patients, pharmacies, and wholesalers, with instructions for healthcare professionals to stop supplying the batch, quarantine remaining stock, and return it to the supplier.

The recall is classified as a Class 2 Patient, Pharmacy and Wholesaler recall, requiring halt of supply, quarantine of remaining stock, and return to the supplier.

Ramipril is used to treat high blood pressure, heart failure, and to reduce the risk of stroke, heart attack, and kidney problems after a heart event by widening blood vessels.

Pharmacy professionals should identify and contact all patients who received the impacted product, prioritizing the most recently dispensed ones, to confirm if they have stock to return.

Pharmacists should reach out to patients dispensed the product, focusing on those in the last 28 days, and advise them to check packaging for correct medication.

MHRA advises stopping supply of the affected batch and returning remaining stock; patients should seek medical advice if they’ve taken the wrong dose and report adverse reactions via the Yellow Card scheme.

Adverse reactions should be reported through the MHRA Yellow Card scheme.